Medical care costs of Paget's disease of bone in a privately insured population

Bone

Volumn 38, Issue 5, 2006, Pages 731-737

  Briesacher, Becky A ^a   Orwig, Denise ^b   Seton, Margaret ^c   Omar, Mohamed ^d   Kahler, Kristijan H ^d  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Association; Autism; LD; PDT; Reelin

Indexed keywords

ALENDRONIC ACID; ANALGESIC AGENT; ANTIPYRETIC AGENT; CALCITONIN; ETIDRONIC ACID; OPIATE ANTAGONIST; RISEDRONIC ACID; SALICYLIC ACID DERIVATIVE; TILUDRONIC ACID;

ADULT; AGED; ARTICLE; CHI SQUARE TEST; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC TEST; EMPLOYEE; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH INSURANCE; HEALTH SERVICE; HEARING LOSS; HEART MURMUR; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LONGITUDINAL STUDY; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTPATIENT; PAGET BONE DISEASE; PATHOLOGIC FRACTURE; PRESCRIPTION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TIME SERIES ANALYSIS; VERTEBRAL CANAL STENOSIS;

AGED; AGED, 80 AND OVER; FEMALE; HEALTH CARE COSTS; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; OSTEITIS DEFORMANS;

EID: 33646472282     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.10.015     Document Type: Article

References (34)

1. Ahmed F., Janes G.R., Baron R., and Latts L.M. Preferred provider organization claims showed high predictive value but missed substantial proportion of adults with high-risk conditions. J. Clin. Epidemiol. 58 (2005) 624-628
2. Altman R.D. Musculoskeletal manifestations of Paget's disease of bone. Arthritis Rheum. 23 (1980) 1121-1127
3. Altman R.D., Bloch D.A., Hochberg M.C., and Murphy W.A. Prevalence of pelvic Paget's disease of bone in the United States. J. Bone Miner. Res. 15 (2000) 461-465
4. Ankrom M.A., and Shapiro J.R. Paget's disease of bone (osteitis deformans). J. Am. Geriatr. Soc. 46 (1998) 1025-1033
5. Ash A.S., Ellis R.P., Pope G.C., Ayanian J.Z., Bates D.W., Burstin H., et al. Using diagnoses to describe populations and predict costs. Health Care Financ. Rev. 21 (2000) 7-28
6. Borzecki A.M., Wong A.T., Hickey E.C., Ash A.S., and Berlowitz D.R. Identifying hypertension-related comorbidities from administrative data: what's the optimal approach?. Am. J. Med. Qual. 19 (2004) 201-206
7. Delmas P.D., and Meunier P.J. The management of Paget's disease of bone. N. Engl. J. Med. 336 (1997) 558-566
8. Dove J. Complete fractures of the femur in Paget's disease of bone. J. Bone Jt. Surg., Br. 62-B (1980) 12-17
9. Drake W.M., Kendler D.L., and Brown J.P. Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000. Clin. Ther. 23 (2001) 620-626
10. Etzioni R., Riley G.F., Ramsey S.D., and Brown M. Measuring costs: administrative claims data, clinical trials, and beyond. Med. Care 40 (2002) III63-III72
11. Franck W.A., Bress N.M., Singer F.R., and Krane S.M. Rheumatic manifestations of Paget's disease of bone. Am. J. Med. 56 (1974) 592-603
12. Gabriel S.E., Tosteson A.N., Leibson C.L., Crowson C.S., Pond G.R., Hammond C.S., et al. Direct medical costs attributable to osteoporotic fractures. Osteoporos. Int. 13 (2002) 323-330
13. Gold D.T., Boisture J., Shipp K.M., Pieper C.F., and Lyles K.W. Paget's disease of bone and quality of life. J. Bone Miner. Res. 11 (1996) 1897-1904
14. Gold D.T., Burchett B.M., Shipp K.M., Pieper C.F., and Lyles K.W. Factors associated with self-rated health in patients with Paget's disease of bone. J. Bone Miner. Res. 14 Suppl 2 (1999) 99-102
15. Grundy M. Fractures of the femur in Paget's disease of bone. Their etiology and treatment. J. Bone Jt. Surg., Br. 52 (1970) 252-263
16. Hamdy R.C., Moore S., and LeRoy J. Clinical presentation of Paget's disease of the bone in older patients. South Med. J. 86 (1993) 1097-1100
17. Hu X.H., Markson L.E., Lipton R.B., Stewart W.F., and Berger M.L. Burden of migraine in the United States: disability and economic costs. Arch. Intern. Med. 159 (1999) 813-818
18. Keen R.W. The current status of Paget's disease of the bone. Hosp. Med. 64 (2003) 230-232
19. Lafuma A., Fagnani F., and Meunier P.J. An economic evaluation of tiludronic acid treatment in Paget's disease of bone. Pharmacoeconomics 12 (1997) 460-474
20. Langston A.L., and Ralston S.H. Management of Paget's disease of bone. Rheumatology (Oxford) 43 (2004) 955-959
21. Mark T.L., and Coffey R.M. What drove private health insurance spending on mental health and substance abuse care, 1992-1999?. Health Aff. (Millwood) 22 (2003) 165-172
22. Melton III L.J., Tiegs R.D., Atkinson E.J., and O'Fallon W.M. Fracture risk among patients with Paget's disease: a population-based cohort study. J. Bone Miner. Res. 15 (2000) 2123-2128
23. Menzin J., Lang K., Friedman M., Neumann P., and Cummings J.L. The economic cost of Alzheimer's disease and related dementias to the California Medicaid program ("Medi-Cal") in 1995. Am. J. Geriatr. Psychiatry 7 (1999) 300-308
24. Mirra J.M., Brien E.W., and Tehranzadeh J. Paget's disease of bone: review with emphasis on radiologic features: Part II. Skelet. Radiol. 24 (1995) 173-184
25. Newton K.M., Wagner E.H., Ramsey S.D., McCulloch D., Evans R., Sandhu N., et al. The use of automated data to identify complications and comorbidities of diabetes: a validation study. J. Clin. Epidemiol. 52 (1999) 199-207
26. Ooi C.G., and Fraser W.D. Paget's disease of bone. Postgrad. Med. J. 73 (1997) 69-74
27. Saifuddin A., and Hassan A. Paget's disease of the spine: unusual features and complications. Clin. Radiol. 58 (2003) 102-111
28. Schneider D., Hofmann M.T., and Peterson J.A. Diagnosis and treatment of Paget's disease of bone. Am. Fam. Phys. 65 (2002) 2069-2072
29. Selby P.L., Davie M.W., Ralston S.H., and Stone M.D. Guidelines on the management of Paget's disease of bone. Bone 31 (2002) 366-373
30. Seton M., Choi H.K., Hansen M.F., Sebaldt R.J., and Cooper C. Analysis of environmental factors in familial versus sporadic Paget's disease of bone-the New England Registry for Paget's Disease of Bone. J. Bone Miner. Res. 18 (2003) 1519-1524
31. Seton M., and Krane S.M. Paget's disease of bone. Curr. Ther. Endocrinol. Metab. 6 (1997) 568-572
32. Tiegs R.D. Paget's disease of bone: indications for treatment and goals of therapy. Clin. Ther. 19 (1997) 1309-1329 [discussion 1523-1524]
33. Tiegs R.D., Lohse C.M., Wollan P.C., and Melton L.J. Long-term trends in the incidence of Paget's disease of bone. Bone 27 (2000) 423-427
34. van Staa T.P., Selby P., Leufkens H.G., Lyles K., Sprafka J.M., and Cooper C. Incidence and natural history of Paget's disease of bone in England and Wales. J. Bone Miner. Res. 17 (2002) 465-471